Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Charalambos Andreadis, Akshay Sudhindra et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 8
Pembrolizumab + GVD with ctdna-guided consolidation for relapsed/refractory classic Hodgkin lymphoma: A multicenter phase 2 Study of the University of California hematologic malignancies consortiumMichael P. Randall, Michael A. Spinner, Wendy Swetzig Dhiman et al.|Blood|2025Cited by 1
A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin LymphomaSwetha Kambhampati, Charalambos Andreadis, Bita Fakhri et al.|Blood|2019Cited by 0